GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » Price-to-Operating-Cash-Flow

Ibex Technologies (TSXV:IBT) Price-to-Operating-Cash-Flow : 14.55 (As of Jun. 09, 2024)


View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies Price-to-Operating-Cash-Flow?

As of today (2024-06-09), Ibex Technologies's share price is C$1.44. Ibex Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.10. Hence, Ibex Technologies's Price-to-Operating-Cash-Flow Ratio for today is 14.55.

The historical rank and industry rank for Ibex Technologies's Price-to-Operating-Cash-Flow or its related term are showing as below:

TSXV:IBT' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.43   Med: 5.53   Max: 45
Current: 14.55

During the past 13 years, Ibex Technologies's highest Price-to-Operating-Cash-Flow Ratio was 45.00. The lowest was 1.43. And the median was 5.53.

TSXV:IBT's Price-to-Operating-Cash-Flow is ranked better than
72.01% of 293 companies
in the Biotechnology industry
Industry Median: 25.29 vs TSXV:IBT: 14.55

Ibex Technologies's Cash Flow from Operations per share for the three months ended in Jan. 2024 was C$0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.10.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Ibex Technologies was 19.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 16.50% per year.

During the past 13 years, Ibex Technologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 84.60% per year. The lowest was -205.50% per year. And the median was 10.30% per year.


Ibex Technologies Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Ibex Technologies's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies Price-to-Operating-Cash-Flow Chart

Ibex Technologies Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 4.91 6.12 3.01 13.68

Ibex Technologies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.72 15.08 13.68 11.49 11.31

Competitive Comparison of Ibex Technologies's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Ibex Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ibex Technologies's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ibex Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Ibex Technologies's Price-to-Operating-Cash-Flow falls into.



Ibex Technologies Price-to-Operating-Cash-Flow Calculation

Ibex Technologies's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=1.44/0.099
=14.55

Ibex Technologies's Share Price of today is C$1.44.
Ibex Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.10.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Ibex Technologies Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Ibex Technologies (TSXV:IBT) Business Description

Traded in Other Exchanges
Address
5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines